Trellus Management Company, LLC Fennec Pharmaceuticals Inc. Call Options Transaction History
Trellus Management Company, LLC
- $69.9 Million
- Q3 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding FENC
# of Institutions
64Shares Held
14.7MCall Options Held
10KPut Options Held
83.8K-
Southpoint Capital Advisors LP New York, NY4.08MShares$26.4 Million0.71% of portfolio
-
Sonic Gp LLC Honolulu, HI2.41MShares$15.6 Million33.54% of portfolio
-
Solas Capital Management, LLC Darien, CT2.25MShares$14.6 Million11.1% of portfolio
-
Black Rock Inc. New York, NY1.19MShares$7.68 Million0.0% of portfolio
-
Dg Capital Management, LLC New York, NY1.11MShares$7.21 Million2.94% of portfolio
About FENNEC PHARMACEUTICALS INC.
- Ticker FENC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,067,300
- Market Cap $169M
- Description
- Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...